18 years in drug development, 10 years in academia & formerly employed at Novozymes and Novo Nordisk.
I’ve worked with a total of 30+ drug development projects and put 5 drugs on the market.
Extensive knowledge in the areas of peptides, proteins, mAbs, ADCs, small molecules, cancer, cardio vascular,
metabolics, haemophilia, personalized medicines, vaccines & inflammation.
Currently involved with CMC & regulatory strategy.
